Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002618726 | SCV002961082 | pathogenic | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly1994Alafs*53) in the PLCE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLCE1 are known to be pathogenic (PMID: 17086182, 20591883). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with PLCE1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1929666). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005042925 | SCV005678417 | pathogenic | Nephrotic syndrome, type 3 | 2024-04-23 | criteria provided, single submitter | clinical testing |